Sima S. Toussi, MD

Pfizer Inc.

Disclosure(s): Pfizer: Stocks/Bonds (Private Company)

Poster(s):

• (P-642) Attributes of Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus (RSV): Results of a Systematic Literature Review
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-704) RSV Signs and Symptoms at Time of Hospitalization among Pediatric and Adult Population with RSV in two Seasons: A Real-World Data Analysis using Electronic Health Records in the US
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-705) Time to Testing, Diagnosis, and Hospitalization Among Pediatric and Adult Patients with RSV in Two Seasons: A Real-World Data Analysis using Electronic Health Records in the US
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET